Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Hypera
Market Cap: R$15.0b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.49
7D
2.4%
1Y
-22.7%